Multi-modal AI for comprehensive breast cancer prognostication
Jan Witowski(Yara (Norway)), Yann LeCun(Courant Institute of Mathematical Sciences), Natalie Klar(New York University), Zoe Steinsnyder(New York Genome Center), Marcus Vetter(University Hospital of Basel), Rafic Beydoun(The Barbara Ann Karmanos Cancer Institute), Yu Zong(The Barbara Ann Karmanos Cancer Institute), Andrew J. Clayburn(Johns Hopkins University), Daniel Baumhoer(University Hospital of Basel), Valerie Speirs(University of Aberdeen), Lajos Pusztai(Yale University), Khalil Choucair(The Barbara Ann Karmanos Cancer Institute), Lina Daoud(The Barbara Ann Karmanos Cancer Institute), Frederick M. Howard(University of Chicago), Kangning Liu(New York University), Soo‐Hwang Teo(Cancer Research Malaysia), Uğur Özerdem(New York University), Jailan A. Elayoubi(The Barbara Ann Karmanos Cancer Institute), Nitya Thakore(New York University), Adam Brufsky(University of Pittsburgh), Carlos Fernandez‐Granda(Courant Institute of Mathematical Sciences), Su Hyun Lim(Catholic University of Korea), Dovile Zilenaite-Petrulaitiene(Vilnius University), Sun‐Young Jun(Catholic University of Korea), Danielle Rigau(New York University), Irina Ostrovnaya(Memorial Sloan Kettering Cancer Center), Waleed Abdulsattar(The Barbara Ann Karmanos Cancer Institute), Elisa Liu(New York University), Freya Schnabel(New York University), Frank Yeung(New York University), Carlo Bifulco(Providence Health & Services), Arvydas Laurinavičius(Brigham and Women's Hospital), Linda M. Pak(New York University), Elena Diana Chiru(Psychiatry Baselland), Young-Joon Kang(Catholic University of Korea), Brian Piening(Providence College), Francisco J. Esteva(Northwell Health), Haslina Makmur(Cancer Research Malaysia), Benjamin Swett(New York University), Jia Wern Pan(Cancer Research Malaysia), Jae Pak Yi(Catholic University of Korea), Nancy Chan(New York University), Mohammad Sadic(New York University), Lina Sojak(Psychiatry Baselland), Joseph Cappadona(Yara (Norway)), Victor Angel(Technological University of Mexico), Anas M. Saad(The Barbara Ann Karmanos Cancer Institute)
Cited by 6
Related Papers
Dictionary learning for integrative, multimodal and scalable single-cell analysis
|Nature Biotechnology|2023|4.9k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
|Journal of Clinical Oncology|2007|1.6k